Discover Our Group:

Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992. 

Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.

Discover More about Global Responsibility

From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet

Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice. 

Discover More about Global Partnering

Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.

Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.

Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.

Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material. 

Menarini Blog

Follow Us

We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.

Our Job Portal

Find out about our current vacancies at Berlin-Chemie directly on our career portal.

Menarini Group News

2021 - 04 - 16

Covid-19: Menarini, new reagent made in Italy for the isolation of viral RNA

Florence, 16 April 2021 - Menarini Diagnostics, a company of the Menarini Group, launches Leasy Kit, an innovative reagent, result of its own research and 100% "made in Italy," for the isolation of viral RNA in molecular swab tests. The Leasy Kit has the advantage of allowing for a considerable saving of time, work and resources while maintaining a high level of performance.

While traditional methods provide for the viral "extraction and purification of RNA" from the patient’s sample with long waiting periods and greater costs, the Menarini Research and Development teams have designed an innovative method.  With the Leasy Kit, the outer membrane of the virus enclosing the RNA is dissolved rapidly, thus releasing the RNA into the solution with great speed, making it available for amplification with Covid-19 molecular tests.

More simply, let's imagine that RNA is a ball inside a bottle with a narrow neck: with the traditional method it must be extracted while with this new technique the bottle is simply broken.

The new reagent, fruit of the research of Menarini Silicon Biosystems in Bologna, is already in production in the specially designed laboratories in Pisa.

"Our Research and Development and Manufacturing teams have worked with great determination in the recent months to bring an innovative solution to laboratories that minimizes the time and costs of molecular routines, while ensuring accurate results and ample flexibility," commented Fabio Piazzalunga, General Manager of Menarini Diagnostics and President of Menarini Silicon Biosystems.  “This is the first Menarini product in molecular diagnostics that has entirely been developed and produced in Italy.  Thanks to the investments made, we are able to offer innovative solutions that allow for the reduction of time and costs.”

The Leasy, being a kit that can be utilized in combination with various amplification tests, has been assigned the “Research Use Only” indication and requires a simple laboratory validation for routine use.